The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
FAK signaling in human cancer as a target for therapeutics
Open accessAbstract
Focal adhesion kinase (FAK) is a key regulator of growth factor receptor- and integrin-mediated signals, governing fundamental processes in normal and cancer cells through its kinase activity and scaffolding function. Increased FAK expression and activity occurs in primary and metastatic cancers of many tissue origins, and is often associated with poor clinical outcome, highlighting FAK as a potential determinant of tumor development and metastasis. Indeed, data from cell culture and animal models of cancer provide strong lines of evidence that FAK promotes malignancy by regulating tumorigenic and metastatic potential through highly-coordinated signaling networks that orchestrate a diverse range of cellular processes, such as cell survival, proliferation, migration, invasion, epithelial-mesenchymal transition, angiogenesis and regulation of cancer stem cell activities. Such an integral role in governing malignant characteristics indicates that FAK represents a potential target for cancer therapeutics. While pharmacologic targeting of FAK scaffold function is still at an early stage of development, a number of small molecule-based FAK tyrosine kinase inhibitors are currently undergoing pre-clinical and clinical testing. In particular, PF-00562271, VS-4718 and VS-6063 show promising clinical activities in patients with selected solid cancers. Clinical testing of rationally designed FAK-targeting agents with implementation of predictive response biomarkers, such as merlin deficiency for VS-4718 in mesothelioma, may help improve clinical outcome for cancer patients. In this article, we have reviewed the current knowledge regarding FAK signaling in human cancer, and recent developments in the generation and clinical application of FAK-targeting pharmacologic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–263 of 263
Loss of Scar/WAVE Complex Promotes N-WASP- and FAK-Dependent Invasion
Tang, H., Li, A., Bi, J., Veltman, D. M., Zech, T., Spence, H. J., Yu, X., Timpson, P., Insall, R. H., Frame, M. C., et al. (2012) · Current Biology · doi:10.1016/j.cub.2012.11.059 · Cited by 87
Self-citationFan, H., Zhao, X., Sun, S., Luo, M., & Guan, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.420497 · Cited by 85
Hurt, E. M., Chan, K. C., Serrat, M. A. D., Thomas, S. B., Veenstra, T. D., & Farrar, W. L. (2009) · Stem Cells · doi:10.1002/stem.271 · Cited by 83
Garces, C., Kurenova, E., Golubovskaya, V., & Cance, W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1661 · Cited by 83
Focal adhesion kinase mediates cell survival via NF-κB and ERK signaling pathways
Huang, D., Khoe, M., Befekadu, M., Chung, S., Takata, Y., Ilić, D., & Bryer‐Ash, M. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00144.2006 · Cited by 82
Kurenova, E., Hunt, D. L., He, D.-H., Magis, A. T., Ostrov, D. A., & Cance, W. G. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900159g · Cited by 80
Bagi, C. M., Roberts, G. W., & Andresen, C. J. (2008) · Cancer · doi:10.1002/cncr.23429 · Cited by 78
FAK overexpression and p53 mutations are highly correlated in human breast cancer
Golubovskaya, V., Conway‐Dorsey, K., Edmiston, S. N., Tse, C., Lark, A. A., Livasy, C., Moore, D., Millikan, R. C., & Cance, W. G. (2009) · International Journal of Cancer · doi:10.1002/ijc.24486 · Cited by 77
Elevated focal adhesion kinase expression facilitates oral tumor cell invasion
Schneider, G. B., Kurago, Z., Zaharias, R. S., Gruman, L. M., Schaller, M. D., & Hendrix, M. J. C. (2002) · Cancer · doi:10.1002/cncr.10992 · Cited by 76
Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer
Park, J. H., Lee, B.-L., Yoon, J., Kim, J., Kim, M. A., Yang, H., & Kim, W. H. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.06.004 · Cited by 75
Self-citationJones, G., Machado, J., Tolnay, M., & Merlo, A. (2001) · PubMed · Cited by 74
Akagi, T., Murata, K., Shishido, T., & Hanafusa, H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7015-7023.2002 · Cited by 74
Sakurama, K., Noma, K., Takaoka, M., Tomono, Y., Watanabe, N., Hatakeyama, S., Ohmori, O., Hirota, S., Motoki, T., Shirakawa, Y., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0884 · Cited by 71
Clinical significance of FAK expression in human neoplasia.
Chatzizacharias, N. A., Kouraklis, G., & Theocharis, S. E. (2008) · PubMed · doi:10.14670/hh-23.629 · Cited by 70
Bagi, C. M., Christensen, J. G., Cohen, D. P., Roberts, W. G., Wilkie, D. P., Swanson, T. A., Tuthill, T. A., & Andresen, C. J. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.9.8246 · Cited by 70
Zheng, Y., Gierut, J. J., Wang, Z., Miao, J., Asara, J. M., & Tyner, A. L. (2012) · Oncogene · doi:10.1038/onc.2012.427 · Cited by 63
Golubovskaya, V., Ho, B., Zheng, M., Magis, A. T., Ostrov, D. A., Morrison, C., & Cance, W. G. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-342 · Cited by 62
Distinct FAK Activities Determine Progenitor and Mammary Stem Cell Characteristics
Luo, M., Zhao, X., Chen, S., Liu, S., Wicha, M. S., & Guan, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1351 · Cited by 62
Su, J.-M., 桂律, 周一平, & Zha, X. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i4.613 · Cited by 61
Mel, L. O. B. O., & Zachary, I. C. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3547 · Cited by 59
Crompton, B. D., Carlton, A. L., Thorner, A. R., Christie, A. L., Du, J., Calicchio, M. L., Rivera, M. N., Fleming, M. D., Kohl, N. E., Kung, A. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1944 · Cited by 58
Huang, Y.-T., Lee, L.-T., Lee, P. H., Lin, Y., & Lee, M. (2005) · PubMed · Cited by 58
Serrels, A., McLeod, K., Canel, M., Kinnaird, A., Graham, K., Frame, M. C., & Brunton, V. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26351 · Cited by 57
Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer
Shah, N. R., Tancioni, I., Ward, K. K., Lawson, C., Chen, X. L., Jean, C., Sulzmaier, F. J., Uryu, S. A., Miller, N. L. G., Connolly, D. C., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.04.044 · Cited by 57
Increased Expression of Focal Adhesion Kinase in Thyroid Cancer: Immunohistochemical Study
Kim, S. J., Park, J., Yoon, J. S., Mok, J., Kim, Y. J., Park, H. K., Kim, C., Byun, D. W., Lee, Y. J., Jin, S. Y., et al. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.5.710 · Cited by 57
Sonoda, Y., Kasahara, T., Aizu-Yokota, E., Ueno, M., & Watanabe, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7895 · Cited by 56
Kurio, N., Shimo, T., Fukazawa, T., Takaoka, M., Okui, T., Hassan, N. M. M., Honami, T., Hatakeyama, S., Ikeda, M., Naomoto, Y., et al. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.008 · Cited by 56
Tsujioka, M., Machesky, L. M., Cole, S. L., Yahata, K., & Inouye, K. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80169-9 · Cited by 56
Focal Adhesion Kinase and E-Cadherin as Markers for Nodal Metastasis in Laryngeal Cancer
Rodrigo, J. P., Dominguez, F., Suárez, V., Canel, M., Secades, P., & Chiara, M. (2007) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.133.2.145 · Cited by 56
Src‐dependent autophagic degradation of Ret in FAK‐signalling‐defective cancer cells
Sandilands, E., Serrels, B., Wilkinson, S., & Frame, M. C. (2012) · EMBO Reports · doi:10.1038/embor.2012.92 · Cited by 54
Wei, J., Wei, L., Zhou, X., Lu, Z., Francis, K. R., Hu, X., Liu, Y., Xiong, W., Zhang, X., Banik, N. L., et al. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21530 · Cited by 53
Watanabe, N., Takaoka, M., Sakurama, K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4755 · Cited by 53
Focal Adhesion Kinase Overexpression in Endometrial Neoplasia
Livasy, C., Moore, D., Cance, W. G., & Lininger, R. A. (2004) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200412000-00009 · Cited by 50
Menon, R., Deng, M., Rüenauver, K., Queisser, A., Pfeifer, M., Offermann, A., Boehm, D., Vogel, W., Scheble, V. J., Fend, F., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4274 · Cited by 49
Disruption of the protein interaction between FAK and IGF-1R inhibits melanoma tumor growth
Uçar, D. A., Kurenova, E., Garrett, T. J., Cance, W. G., Nyberg, C., Cox, A., Massoll, N. A., Ostrov, D. A., Lawrence, N. J., Sebti, S. M., et al. (2012) · Cell Cycle · doi:10.4161/cc.21611 · Cited by 49
FAK-heterozygous mice display enhanced tumour angiogenesis
Kostourou, V., Lechertier, T., Reynolds, L. E., Lees, D. M., Baker, M., Jones, D. T., Tavora, B., Ramjaun, A. R., Birdsey, G. M., Robinson, S. D., et al. (2013) · Nature Communications · doi:10.1038/ncomms3020 · Cited by 49
Stone, R. L., Baggerly, K., Armaiz-Peña, G. N., Kang, Y., Sanguino, A. M., Thanapprapasr, D., Dalton, H. J., Bottsford-Miller, J. N., Zand, B., Akbani, R., et al. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28882 · Cited by 49
Heffler, M., Golubovskaya, V., Dunn, K. M. B., & Cance, W. G. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25185 · Cited by 46
Lee, B. Y., Hochgräfe, F., Lin, H., Castillo, L. E., Wu, J., Raftery, M. J., Shreeve, S. M., Horvath, L. G., & Daly, R. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0225-t · Cited by 46
Self-citationFocal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells
Ridgway, R. A., Serrels, B., Mason, S. M., Kinnaird, A., Muir, M., Patel, H., Muller, W. J., Sansom, O. J., & Brunton, V. G. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs284 · Cited by 45
A novel strategy to inhibit FAK and IGF‐1R decreases growth of pancreatic cancer xenografts
Zheng, D., Golubovskaya, V., Kurenova, E., Wood, C., Massoll, N. A., Ostrov, D. A., Cance, W. G., & Hochwald, S. N. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20590 · Cited by 43
Th, C., Pc, C., Cl, C., & Hc, C. (2010) · Oncogene · doi:10.1038/onc.2010.398 · Cited by 39
Rodrigo, J. P., Álvarez‐Alija, G., Menéndez, S. T., Mancebo, G., Allonca, E., García‐Carracedo, D., Fresno, M. F., Suarez, C. M., & Garcia-Pedrero, J. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0338 · Cited by 39
Chen, Y., Wang, Z., Chang, P., Xiang, L., Pan, F., Li, J., Jiang, J., Zou, L., Li, Y., Bian, Z., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25025 · Cited by 38
Kamarajan, P., & Kapila, Y. L. (2007) · APOPTOSIS · doi:10.1007/s10495-007-0138-9 · Cited by 37
TAE226 Inhibits Human Neuroblastoma Cell Survival
Beierle, E. A., Trujillo, A., Nagaram, A., Golubovskaya, V., Cance, W. G., & Kurenova, E. (2008) · Cancer Investigation · doi:10.1080/07357900701577475 · Cited by 36
Yu, H., Tong, S., Ding, Y., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22207 · Cited by 34
Sun, H., Pisle, S. T., Gardner, E. R., & Figg, W. D. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.1.11993 · Cited by 34
Signaling of the direction-sensing FAK/RACK1/PDE4D5 complex to the small GTPase Rap1
Serrels, B., Sandilands, E., & Frame, M. C. (2011) · Small GTPases · doi:10.4161/sgtp.2.1.15137 · Cited by 33
Miller, N. L. G., Lawson, C., Kleinschmidt, E. G., Tancioni, I., Uryu, S. A., & Schlaepfer, D. D. (2013) · Journal of Cell Science · doi:10.1242/jcs.135509 · Cited by 33
Graham, K., Moran‐Jones, K., Sansom, O. J., Brunton, V. G., & Frame, M. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027806 · Cited by 31
Wu, Z., Yuan, X.-H., Jiang, P., Li, Z., & Wu, T. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9025-9 · Cited by 30
Lahlou, H., Sanguin‐Gendreau, V., Frame, M. C., & Muller, W. J. (2012) · Breast Cancer Research · doi:10.1186/bcr3131 · Cited by 29
Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma
Kurio, N., Shimo, T., Fukazawa, T., Okui, T., Hassan, N. M. M., Honami, T., Horikiri, Y., Hatakeyama, S., Takaoka, M., Naomoto, Y., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.019 · Cited by 28
Saito, Y., Mori, S., Yokote, K., Kanzaki, T., Saitō, Y., & Morisaki, N. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0978 · Cited by 27
Fang, X., Liu, X., Yao, L., Chen, C.-Q., Gu, Z., Ni, P., Zheng, X., & Fan, Q. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.11.134 · Cited by 25
Alexopoulou, A. N., Ho-Yen, C., Papalazarou, V., Elia, G., Jones, J. L., & Hodivala‐Dilke, K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-237 · Cited by 24
Takahashi, R., Sonoda, Y., Ichikawa, D., Yoshida, N., Aizu-Yokota, E., & Tadashi, K. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.11.011 · Cited by 22
Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance
Chen, Y., Wang, Z., Chang, P., Li, J., Pan, F., Li, Y., Bian, Z., Zou, L., He, J., & Liang, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01217.x · Cited by 22
Yao, L., Li, K., Peng, W., Lin, Q., Li, S., Hu, X., Zheng, X., & Shao, Z. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-136 · Cited by 21
New Insights into FAK Phosphorylation Based on a FAT Domain-Defective Mutation
Fang, X., Liu, X., Yao, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107134 · Cited by 18
Soria, J., Gan, H. K., Arkenau, H., Blagden, S. P., Plummer, R., Ranson, M., Evans, T. R. J., Zalcman, G., Bahleda, R., Hollebecque, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.3000 · Cited by 14
Hirt, U. A., Braunger, J., Schleicher, M., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-11-a249 · Cited by 12
Cited by
Every step of the way: integrins in cancer progression and metastasis
Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
PROTACs: great opportunities for academia and industry
Sun, X., Gao, H., Yang, Y., He, M., Wu, Y., Song, Y., Tong, Y., & Rao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0101-6 · Cited by 613
Lampi, M. C., & Reinhart-King, C. A. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0475 · Cited by 551
PROTACs: An Emerging Therapeutic Modality in Precision Medicine
Nalawansha, D. A., & Crews, C. M. (2020) · Cell Chemical Biology · doi:10.1016/j.chembiol.2020.07.020 · Cited by 490
Metadata
- Authors
- Lee, B. Y., Timpson, P., Horvath, L. G., & Daly, R. J.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 146
- Pages
- 132-149
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2012347139
- Cited by
- 425
- References
- 263
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.